000 | 01979 a2200457 4500 | ||
---|---|---|---|
005 | 20250515174319.0 | ||
264 | 0 | _c20090831 | |
008 | 200908s 0 0 eng d | ||
022 | _a1744-9987 | ||
024 | 7 |
_a10.1111/j.1744-9987.2009.00684.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTriantafyllou, Nik I | |
245 | 0 | 0 |
_aPeriodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up. _h[electronic resource] |
260 |
_bTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy _cJun 2009 |
||
300 |
_a174-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyasthenia Gravis _xtherapy |
650 | 0 | 4 |
_aPlasma Exchange _xadverse effects |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRemission Induction _xmethods |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aGrapsa, Eirini Ioannis | |
700 | 1 | _aKararizou, Evangelia | |
700 | 1 | _aPsimenou, Erasmia | |
700 | 1 | _aLagguranis, Antonios | |
700 | 1 | _aDimopoulos, Athanasios | |
773 | 0 |
_tTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy _gvol. 13 _gno. 3 _gp. 174-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1744-9987.2009.00684.x _zAvailable from publisher's website |
999 |
_c18946514 _d18946514 |